Clinical trial · Observational
PET/MRI Perfusion and CT Perfusion in Solid Tumors
Diagnostic and Clinical Accuracy of Integrated Magnetic Resonance Imaging and Computed Tomography Perfusion in PET/MRI in Comparison to PET/CT in Solid Tumors
NCT02314962CI-TRIAL-00025196PerfusionterminatedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Slow enrolment
Summary
Brief summary (as posted)
Diagnostic comparison between PET/CT and PET/MRI with integrated perfusion measurement in CT and MR. Study aim is to gain knowledge about additional value of CT perfusion and MR perfusion in solid tumors concerning tumor physiology, diagnostic accuracy and possibly prognostic.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| CT Perfusion and MRI Perfusion in Solid Tumors | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Measurement of blood flow, blood volume and transfer constant (Ktrans) with CT-Perfusion and PET/MR-perfusion in solid tumors.
- timeFrame
- 18 months
Secondary outcomes (1)
- measure
- Correlation of blood flow, blood volume and transfer constant (Ktrans) measured with CT-Perfusion and PET/MR-perfusion with progression free survival in solid tumors.
- timeFrame
- 18 months
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 30 Years
- Maximum age
- 90 Years
Show eligibility criteria text
Inclusion Criteria: * indication as stated above * written informed consent * patients with suspected or confirmed solid malignant tumors of the neck, chest or abdomen who have an indication for a PET/CT Exclusion Criteria: * pregnant or breast feeding women * non compliance of the patient to follow the study instructions (e.g. hearing problems, dementia) * Inclusion in another clinical trial 30 days prior to inclusion * age \< 30years * contraindication for MRI (cardiac pacemaker, certain metal implants, claustrophobia * known allergies to contrast CT or MRI contrast media * patients with an glomerular filtration rate of \< 60ml/min/1.73m2
References
Publications (0)
Data not yet available
No reference posted for this study.